FDA.reportPublic FDA data

ASPARTAME

Substance profile for UNII Z0H242BBR1, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for ASPARTAME
Structure render from NCI/CADD chemical resolver

Substance Identity#

UNII
Z0H242BBR1
Preferred term
ASPARTAME
Registry number
22839-47-0
EC number
245-261-3
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C14H18N2O5
Chemical structure for ASPARTAME
Structure render from NCI/CADD chemical resolver

Chemical And Database Identifiers#

InChIKey
IAOZJIPTCAWIRG-QWRGUYRKSA-N
SMILES
COC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](N)CC(O)=O
RxCUI
1311524
PubChem
0
NCIt
C76513
INN ID
3019

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem InChIKey SearchIAOZJIPTCAWIRG-QWRGUYRKSA-Npubchem.ncbi.nlm.nih.gov/#query=IAOZJIPTCAWIRG-QWRGUYRKSA-N
RxNorm1311524mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1311524
NCI ThesaurusC76513ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C76513
FDA Substance Registration SystemZ0H242BBR1precision.fda.gov/uniisearch/srs/unii/Z0H242BBR1
European Community number245-261-3commonchemistry.cas.org/results?q=245-261-3

DailyMed Socrata Ingredients#

Type, DailyMed label, SPL version table
TypeDailyMed labelSPL version
INACTIVE INGREDIENT24fdfded-5d47-07a4-e054-00144ff8d46c2
INACTIVE INGREDIENTThese highlights do not include all the information needed to use MONTELUKAST SODIUM CHEWABLE TABLETS safely and effectively. See full prescribing information for MONTELUKAST SODIUM CHEWABLE TABLETS. Montelukast Sodium Chewable Tablets, for oral use Initial U.S. Approval: 19982
INACTIVE INGREDIENTDrug Facts3
INACTIVE INGREDIENTThese highlights do not include all the information needed to use MONTELUKAST SODIUM TABLETS and MONTELUKAST SODIUM CHEWABLE TABLETS safely and effectively. See full prescribing information for MONTELUKAST SODIUM TABLETS and MONTELUKAST SODIUM CHEWABLE TABLETS. Montelukast Sodium Tablets, for oral use. Montelukast Sodium Chewable Tablets, for oral use. Initial U.S. Approval: 19983
INACTIVE INGREDIENTDaytime Flu and Severe2
INACTIVE INGREDIENTNighttime Flu and Severe2
INACTIVE INGREDIENTAMOXICILLIN AND CLAVULANATE POTASSIUM FOR ORAL SUSPENSION, USP 600 mg/42.9 mg per 5 mL1
INACTIVE INGREDIENTOndansetron Orally Disintegrating Tablets5
INACTIVE INGREDIENTONDANSETRON4
INACTIVE INGREDIENTKroger ® DayTime Flu + Severe Cold & Cough2
INACTIVE INGREDIENTKroger ® NiteTime Flu + Severe Cold & Cough2
ACTIVE INGREDIENTDRUG FACTS:2
ACTIVE MOIETYDRUG FACTS:2
INACTIVE INGREDIENTRite Aid ® Daytime Severe Cold & Cough Relief2
INACTIVE INGREDIENTRite Aid ® Nighttime Severe Cold & Cough Relief2
INACTIVE INGREDIENTDrug Facts3
INACTIVE INGREDIENTDrug Facts1
INACTIVE INGREDIENTHEB ® DayTime Flu & Severe Cold & Cough1
ACTIVE INGREDIENTDRUG FACTS:2
ACTIVE MOIETYDRUG FACTS:2
INACTIVE INGREDIENTOndansetron Orally Disintegrating Tablets, USP Rx only2
INACTIVE INGREDIENTOndansetron Orally Disintegrating Tablets, USP Rx only2
INACTIVE INGREDIENTChildren's Mucinex® Mini-Melts™ Cough3
INACTIVE INGREDIENTTopCare Daytime Severe Cold and Cough Berry infused with Menthol and Green Tea flavors2
INACTIVE INGREDIENTTopcare Nighttime Severe Cold and Cough Honey lemon infused with Chamomile and White tea flavors2
INACTIVE INGREDIENTThese highlights do not include all the information needed to use montelukast sodium safely and effectively. See full prescribing information for montelukast sodium. Montelukast Sodium Tablets and Montelukast Sodium Chewable Tablets Initial U.S. Approval:19981001
INACTIVE INGREDIENTDrug Facts1
INACTIVE INGREDIENTAmoxicillin and Clavulanate Potassium 600 mg/42.9 mg per 5 mL Powder for Oral Suspension1
INACTIVE INGREDIENTGuardian Sugar free Natural Fiber Orange flavor2
INACTIVE INGREDIENTChildrens Allegra Allergy-ODT12
INACTIVE INGREDIENTTravel Sickness3
INACTIVE INGREDIENTPRESCRIBING INFORMATION ONDANSETRON ORALLY DISINTEGRATING TABLETS, USP Rx only3
INACTIVE INGREDIENTDrug Facts1
INACTIVE INGREDIENTAmoxicillin and Clavulanate Potassium 600 mg/42.9 mg per 5 mL Powder for Oral Suspension2
INACTIVE INGREDIENTThese highlights do not include all the information needed to use amoxicillin and clavulanate potassium for oral suspension, USP safely and effectively. See full prescribing information for amoxicillin and clavulanate potassium for oral suspension, USP. Amoxicillin and Clavulanate Potassium for Oral Suspension, USP Initial U.S. Approval: 1984 To reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin and clavulanate potassium for oral suspension and other antibacteria1
INACTIVE INGREDIENTThese highlights do not include all the information needed to use olanzapine orally disintegrating tablets safely and effectively. See full prescribing information for olanzapine orally disintegrating tablets. Olanzapine Orally Disintegrating Tablets for Oral use Initial U.S. Approval: 19962
INACTIVE INGREDIENTCLARITHROMYCIN TABLETS, USP AND CLARITHROMYCIN FOR ORAL SUSPENSION, USP Rx only4
INACTIVE INGREDIENTShopRite Ibuprofen IB Drug Facts1
INACTIVE INGREDIENTAMOXICILLIN AND CLAVULANATE POTASSIUM FOR ORAL SUSPENSION, USP, 600 mg/42.9 mg per 5 mL Rx only2
INACTIVE INGREDIENTPerrigo Tussin DM Drug Facts1
INACTIVE INGREDIENTCVS Pharmacy Daytime Nighttime Severe Cold & Cough Kit3
INACTIVE INGREDIENTDrug Facts1
INACTIVE INGREDIENTd2b9e29f-7cc8-470b-9546-9614f8eda1991
INACTIVE INGREDIENTCVS Pharmacy Daytime Severe Cough and Cold Berry infused with Menthol and Green Tea flavors2
INACTIVE INGREDIENTCVS Pharmacy Nighttime Severe Cough and Cold Honey lemon infused with Chamomile and White tea flavors4
INACTIVE INGREDIENTOnce-A-Day Mirtazapine Orally Disintegrating Tablets1
INACTIVE INGREDIENTTravel Sickness1000
INACTIVE INGREDIENTScot-Tussin Senior SF DMEXP5
INACTIVE INGREDIENTScot-Tussin Expectorant SF Cough4
INACTIVE INGREDIENTThese highlights do not include all the information needed to use SINGULAIR safely and effectively. See full prescribing information for SINGULAIR. SINGULAIR ® (montelukast sodium) Tablets, Chewable Tablets, and Oral Granules Initial U.S. Approval: 19981000
INACTIVE INGREDIENTThese highlights do not include all the information needed to use SINGULAIR safely and effectively. See full prescribing information for SINGULAIR. SINGULAIR ® (montelukast sodium) Tablets, Chewable Tablets, and Oral Granules Initial U.S. Approval: 19981000
INACTIVE INGREDIENTTravel Sickness2
INACTIVE INGREDIENTafbcbf79-e7cd-4615-a999-9941573882b52
INACTIVE INGREDIENTDrug Facts3
INACTIVE INGREDIENTDrug Facts1
INACTIVE INGREDIENTSunmark Fiber Smooth texture Sugar free Orange flavor1
INACTIVE INGREDIENTDrug Facts3
INACTIVE INGREDIENTThese highlights do not include all the information needed to use montelukast sodium safely and effectively. See full prescribing information for montelukast sodium. MONTELUKAST SODIUM tablets and chewable tablets for oral use Initial U.S. Approval: 19982
INACTIVE INGREDIENTDrug Facts5
INACTIVE INGREDIENTDrug Facts2
INACTIVE INGREDIENTAmoxicillin and Clavulanate Potassium Powder for Oral Suspension and Chewable Tablets1
INACTIVE INGREDIENTDrug Facts2
INACTIVE INGREDIENTDrug Facts1
INACTIVE INGREDIENTOndansetron Tablets USP Ondansetron Orally Disintegrating Tablets USP1
INACTIVE INGREDIENTOndansetron Tablets USP Ondansetron Orally Disintegrating Tablets USP1
INACTIVE INGREDIENTThese highlights do not include all the information needed to use Staxyn safely and effectively. See full prescribing information for Staxyn. STAXYN (vardenafil hydrochloride) orally disintegrating tablets Initial U.S. Approval: 20033
INACTIVE INGREDIENTThese highlights do not include all the information needed to use CAMBIA safely and effectively. See full prescribing information for CAMBIA. CAMBIA (Diclofenac Potassium for Oral Solution) Initial U.S. Approval: 19884
INACTIVE INGREDIENTThese highlights do not include all the information needed to use MAXALT and MAXALT-MLT safely and effectively. See full prescribing information for MAXALT and MAXALT-MLT. MAXALT (rizatriptan benzoate) tablets, for oral use MAXALT-MLT (rizatriptan benzoate) orally disintegrating tablets Initial U.S. Approval: 19982
INACTIVE INGREDIENTThese highlights do not include all the information needed to use olanzapine safely and effectively. See full prescribing information for olanzapine orally disintegrating tablets. Olanzapine Orally Disintegrating Tablets, for Oral use Initial U.S. Approval: 19964
INACTIVE INGREDIENTThese highlights do not include all the information needed to use SINGULAIR safely and effectively. See full prescribing information for SINGULAIR. SINGULAIR ® (montelukast sodium) Tablets, Chewable Tablets, and Oral Granules Initial U.S. Approval: 19981
INACTIVE INGREDIENTThese highlights do not include all the information needed to use APRISO safely and effectively. See full prescribing information for APRISO. APRISO™ (mesalamine) extended-release capsules Initial U.S. Approval: 19872
INACTIVE INGREDIENTThese highlights do not include all the information needed to use Welchol safely and effectively. See full prescribing information for Welchol. Welchol (colesevelam hydrochloride) Tablet, Film Coated, for Oral Welchol (colesevelam hydrochloride) For Suspension, for Oral Initial U.S. Approval: 20002
INACTIVE INGREDIENTDRUG FACTS1
INACTIVE INGREDIENTDRUG FACTS1
INACTIVE INGREDIENTOndansetron Tablets USP Ondansetron Orally Disintegrating Tablets USP3
INACTIVE INGREDIENTAmerisource Bergen Complete Drug Facts1
INACTIVE INGREDIENTOndansetron Tablets USP Ondansetron Orally Disintegrating Tablets USP1
INACTIVE INGREDIENT08d06e6f-a1d8-4bd9-b851-d63858d55f912
INACTIVE INGREDIENTDrug Facts2
ACTIVE INGREDIENTAllergies1
ACTIVE MOIETYAllergies1
ACTIVE INGREDIENTFood Allergy - Additive1
ACTIVE MOIETYFood Allergy - Additive1
INACTIVE INGREDIENTThese highlights do not include all the information needed to use Welchol safely and effectively. See full prescribing information for Welchol. Welchol (colesevelam hydrochloride) Tablet, Film Coated, for Oral Welchol (colesevelam hydrochloride) For Suspension, for Oral Initial U.S. Approval: 20001
INACTIVE INGREDIENTc6d3c1ff-d873-4903-befa-c0ba47034c6e1
INACTIVE INGREDIENTThese highlights do not include all the information needed to use lansoprazole delayed-release orally disintegrating tablets safely and effectively. See full prescribing information for lansoprazole delayed-release orally disintegrating tablets. LANSOPRAZOLE delayed-release orally disintegrating tablets for oral use Initial U.S. Approval: 19951
INACTIVE INGREDIENTAmoxicillin and Clavulanate Potassium2
INACTIVE INGREDIENTDrug Facts1
INACTIVE INGREDIENTOndansetron Orally Disintegrating Tablets, USP2
INACTIVE INGREDIENTa5fa252a-d39e-4099-a230-b665fbb97a801
INACTIVE INGREDIENTbabf3b8d-f2ce-407d-9407-728c45eb19ee1
INACTIVE INGREDIENTThese highlights do not include all the information needed to use PREVACID safely and effectively. See full prescribing information for: PREVACID (lansoprazole) Delayed-Release Capsules PREVACID SoluTab (lansoprazole) Delayed-Release Orally Disintegrating Tablets For oral administration Initial U.S. Approval: 19952
INACTIVE INGREDIENTnight time wal-flu severe cold and cough honey lemon flavor infused with chamomile and white tea flavors8
INACTIVE INGREDIENTDay time Severe Cold and Cough berry infused with menthol and green tea flavors3
INACTIVE INGREDIENTnight time severe cold and cough honey lemon infused with chamomile and white tea flavors3
INACTIVE INGREDIENTDay time Cough and Severe Cold berry infused with menthol and green tea flavors7
INACTIVE INGREDIENTcough and severe cold night time honey lemon infused with chamomile and white tea flavors2
INACTIVE INGREDIENTDay time Severe Cold and cough berry infused with menthol and green tea flavors2
INACTIVE INGREDIENTnight time severe cold and cough honey lemon infused with chamomile and white tea flavors2
INACTIVE INGREDIENTDay time Severe Cold and Cough berry infused with menthol and green tea flavors2
INACTIVE INGREDIENTnight time severe cold and cough honey lemon infused with chamomile and white tea flavors2
INACTIVE INGREDIENTDay time Severe Cold and cough berry infused with menthol and green tea flavors2
INACTIVE INGREDIENTnight time severe cold and cough honey lemon with chamomile and white tea flavors2
INACTIVE INGREDIENTDay time Severe Cold and Cough berry infused with menthol and green tea flavors2
INACTIVE INGREDIENTnight time severe cold and cough honey lemon infused with chamomile and white tea flavors2
INACTIVE INGREDIENT571577b1-2160-4c2f-b953-062c15373fcb3
INACTIVE INGREDIENTb897c800-24a2-4e76-8668-498c5515c3d01
INACTIVE INGREDIENTONDANSETRON TABLET, ORALLY DISINTEGRATING [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3999
INACTIVE INGREDIENTONDANSETRON TABLET, ORALLY DISINTEGRATING [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3925
INACTIVE INGREDIENTSINGULAIR (MONTELUKAST SODIUM) TABLET, CHEWABLE SINGULAIR (MONTELUKAST SODIUM) TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3686
INACTIVE INGREDIENTMIRTAZAPINE TABLET, ORALLY DISINTEGRATING [BRYANT RANCH PREPACK]1001
INACTIVE INGREDIENTMONTELUKAST SODIUM TABLET, CHEWABLE [BRYANT RANCH PREPACK]1001
INACTIVE INGREDIENTMIRTAZAPINE TABLET, ORALLY DISINTEGRATING [BRYANT RANCH PREPACK]1000
INACTIVE INGREDIENTMIRTAZAPINE TABLET, ORALLY DISINTEGRATING [BRYANT RANCH PREPACK]1000
INACTIVE INGREDIENTMIRTAZAPINE TABLET, ORALLY DISINTEGRATING [BRYANT RANCH PREPACK]1000
INACTIVE INGREDIENTONDANSETRON TABLET, ORALLY DISINTEGRATING [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]456
INACTIVE INGREDIENTABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]56
INACTIVE INGREDIENTISENTRESS (RALTEGRAVIR) TABLET, FILM COATED ISENTRESS (RALTEGRAVIR) TABLET, CHEWABLE ISENTRESS (RALTEGRAVIR) GRANULE, FOR SUSPENSION [MERCK SHARP & DOHME CORP.]49
INACTIVE INGREDIENTSINGULAIR (MONTELUKAST SODIUM) GRANULE SINGULAIR (MONTELUKAST SODIUM) TABLET, CHEWABLE SINGULAIR (MONTELUKAST SODIUM) TABLET, FILM COATED [MERCK SHARP & DOHME CORP.]48
INACTIVE INGREDIENTZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]45

Inactive Ingredient Database#

Browse recovered IID releases and source provenance.

Current IID rows for UNII Z0H242BBR1 page 1 of 1 · 19 matching rows.

Ingredient, UNII, CAS table
IngredientUNIICASDosage formRoutePotencyMaximum daily exposure
ASPARTAMEZ0H242BBR122839470FILM, EXTENDED RELEASEBUCCAL1 mg
ASPARTAMEZ0H242BBR122839470CAPSULE, EXTENDED RELEASEORAL3 mg
ASPARTAMEZ0H242BBR122839470GRANULE, EFFERVESCENTORAL30 mg
ASPARTAMEZ0H242BBR122839470GRANULE, FOR SUSPENSIONORAL420 mg
ASPARTAMEZ0H242BBR122839470LOZENGEORAL136 mg
ASPARTAMEZ0H242BBR122839470POWDERORAL63 mg
ASPARTAMEZ0H242BBR122839470POWDER, FOR SOLUTIONORAL233 mg
ASPARTAMEZ0H242BBR122839470POWDER, FOR SUSPENSIONORAL420 mg
ASPARTAMEZ0H242BBR122839470SOLUTIONORAL40 mg
ASPARTAMEZ0H242BBR122839470SUSPENSIONORAL23 mg
ASPARTAMEZ0H242BBR122839470SYRUPORAL0.63 mg/5ml
ASPARTAMEZ0H242BBR122839470TABLETORAL87 mg
ASPARTAMEZ0H242BBR122839470TABLET, CHEWABLEORAL195 mg
ASPARTAMEZ0H242BBR122839470TABLET, CHEWABLE, EXTENDED RELEASEORAL18 mg
ASPARTAMEZ0H242BBR122839470TABLET, FILM COATEDORAL20 mg
ASPARTAMEZ0H242BBR122839470TABLET, FOR SUSPENSIONORAL15 mg
ASPARTAMEZ0H242BBR122839470TABLET, ORALLY DISINTEGRATINGORAL180 mg
ASPARTAMEZ0H242BBR122839470TABLET, ORALLY DISINTEGRATING, DELAYED RELEASEORAL78 mg
ASPARTAMEZ0H242BBR122839470TABLETSUBLINGUAL8 mg